Zdrowie i gospodarka · 08/08/2024

FDA Renews Blood Products Advisory Committee Charter for 2 Years

The Food and Drug Administration (FDA) has renewed the Blood Products Advisory Committee charter for an additional 2 years, with the new term set to expire on May 13, 2026, following a determination by the Commissioner of Food and Drugs that it is in the public interest to do so.